Clinical Trial Update: Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT) [Phase 3]

View source ↗

Summary

Phase 3 trial in locally advanced or metastatic adrenocortical carcinoma completed; results were posted in 2016 as part of the FIRM-ACT study evaluating a regim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenocortical Carcinoma

Drugs mentioned

• Adriamycin (doxorubicin)
• LYSODREN (MITOTANE)
• Platinol (cisplatin)
• VePesid (etoposide)

Snippet

Sponsor: Collaborative Group for Adrenocortical Carcinoma Treatment | Conditions: Carcinoma, Adrenal Cortical | Phase 3 | Status: COMPLETED | Results posted: 2016-09-21